Trilantic North America inks $945m sale of SOFIE Biosciences to GE HealthCare

Published on October 5, 2026

SOFIE Biosciences runs a US network of 15 contract manufacturing sites operating 21 cyclotrons for PET radiopharmaceuticals.

The post Trilantic North America inks $945m sale of SOFIE Biosciences to GE HealthCare appeared first on PE Hub.